New York, NY (February 2, 2010) – Clinilabs is pleased to announce the release of Clinical InSite™, a document management solution for clinical trials that significantly reduces the cost of information management, and that provides novel workflow options that cut the cost of clinical monitoring and auditing. [more]
MINNEAPOLIS--(BUSINESS WIRE)--Feb 3, 2010 - Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has relaunched its flagship drug information reference as Facts & Comparisons eAnswers. [more]
Redwood Shores, CA – February 2, 2010--Builds on Oracle’s Endeavor to Provide an Integrated Pharmacovigilance Suite That Supports End-to-End Drug Safety Processes Across Clinical Development and Post-Market Surveillance [more]
New York, NY (February 2, 2010) – Clinilabs is pleased to announce the release of Clinical InSite, a document management solution for clinical trials that significantly reduces the cost of information management, and that provides novel workflow options that cut the cost of clinical monitoring and auditing. [more]
MALVERN, Pa.--(BUSINESS WIRE)--Feb 1, 2010 - DSG's eCaseLink Electronic Data Capture (EDC) and data management are currently being used by a biotechnology company for two current phase 2 and phase 2a clinical trials for treatments of progressive and chronic kidney disease. [more]
MT. LAUREL, N.J., January 28, 2010 /PRNewswire-FirstCall/ -- MedQuist Inc. , a leading provider of technology-enabled clinical documentation services, issued a statement today outlining its readiness for the extension of Health Information Portability and Accountability Act (HIPAA) security provisions in February 2010 to firms deemed "business associates" of healthcare providers, as well as the provisions of the Health Information Technology for Economic and Clinical Health (HITECH) Act addressing the privacy and security of protected health information (PHI). [more]
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jan 28, 2010 - Cenduit, LLC, and invivodata, inc., today announce a strategic business alliance to further improve clinical trial efficiencies by adding the scientific and operational benefits of invivodata's electronic Patient Reported Outcomes (ePRO) solutions to the proven efficiencies of Cenduit˜s Interactive Response Technology solution (IRT). [more]
Buckingham, England, 22 January - The pioneering In2itive e-Diary combines an integrated spirometer, featuring a removable flow head, with an easy to use touch screen. This versatile ePRO system is the first of its kind and can be customized for use in any protocol-driven clinical trial in a wide range of therapeutic areas. [more]
WALTHAM, Mass.--(BUSINESS WIRE)--Jan 21, 2010 - Phase Forward (NASDAQ: PFWD), a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 of its Empirica™ Signal product, a significant new release of the company's flagship signal detection and management software. The Empirica Signal solution is a state-of-the-art data mining and knowledge management tool and a cornerstone component of Phase Forward's Empirica Suite of pharmacovigilance and risk management products. [more]
BISHOPS STORTFORD, UNITED KINGDOM--(Marketwire - Jan. 14, 2010) -Dotmatics is pleased to announce that it has licensed its enterprise query, reporting, registration and data management tools to The Institute of Cancer Research (ICR). [more]
SAN FRANCISCO, Jan. 13 /PRNewswire/ -- Today, endpoint (www.endpointclinical.com) launched PULSE, a fully configurable system that allows users to design and deploy clinical trial IRT systems in a fraction of the time and cost of other providers. Leveraging a background of more than 12 years designing Integrated Voice Response (IVR/IWR) technology for the Clinical Trial industry, endpoint designed PULSE to balance speed of deployment with flawless quality. PULSE simultaneously designs systems that can be accessed via the phone, web or mobile device. [more]
SAN DIEGO--(BUSINESS WIRE)--Jan 11, 2010 - CliniComp Intl., a global provider of clinical documentation systems, announces that during fourth quarter 2009 four military treatment facilities within the U.S. Navy and Army went live with the Essentris inpatient clinical documentation solution. CliniComp will be demonstrating the Essentris suite at the Society of Critical Care Medicine's Annual Congress in Miami from January 10-12 (booth # 1211). [more]
SAN RAMON, Calif.--(BUSINESS WIRE)--Jan 11, 2010 - Nextrials, Inc., a leader in clinical research software and services, will participate in an integration demonstration between its Prism, an award-winning clinical trial electronic data capture technology, and electronic health records (EHR) platforms used within healthcare systems at the 11th Annual IHE North America Connectathon, being held January 11-15 at the Hyatt Regency Chicago. [more]
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Jan 5, 2010 - Instem, a leading provider of early drug development software solutions, announced today that two Preclinical industry experts are joining the company and will be based out of a new Instem office in Bridgewater, New Jersey. [more]
ST. LOUIS--(BUSINESS WIRE)--Jan 5, 2010 - Pharsight, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, today announced that it has released two new data analysis tools; Phoenix NLME and Phoenix Connect. The tools were developed via a collaborative effort between FDA and Pharsight under Pharsight's previously-announced Cooperative Research and Development Agreement (CRADA) with FDA's Center for Drug Evaluation and Research (CDER). [more]
WALTHAM, Mass.--(BUSINESS WIRE)--Dec 16, 2009 - Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that Cancer Research UK's Drug Development Office – the drug development arm of the world's largest independent organization dedicated to cancer research – is standardizing on Phase Forward's InForm Global Trial Management solution to support its diverse portfolio of early-stage clinical trials. [more]
BOSTON--(BUSINESS WIRE)--Dec 16, 2009 - PHT Corporation announced that Sanofi Pasteur is using PHT's LogPad System and StudyWorks online portal for a Phase II trial to develop a vaccine against the Clostridium difficile bacterium. PHT is the leading provider of ePRO solutions used in pharmaceutical and biotechnology clinical trials worldwide. [more]
SAN FRANCISCO, Dec. 10 /PRNewswire/ -- DecisionView Inc., a leading provider of software solutions to optimize clinical trial enrollment for life sciences companies, today announced the release of StudyOptimizer 4, the latest iteration of its Web-based solution. Currently in use by several major global pharmaceutical companies, DecisionView's flagship product now includes advanced historical analysis and templates capabilities, as well as enhancements to its predictive analytics technology. For the first time, clinical trial managers have a comprehensive 360 degree view of their organization's clinical trial patient recruitment performance at their fingertips with: [more]
Yardley, Pennsylvania, 8 December 2009 -- Almac announced today a unique partnership with FACIT.org for electronic distribution of the latter’s Patient-Reported-Outcomes (PRO) and Quality of Life (QOL) assessments. The partnership agreement empowers Almac to use and validate leading FACT and FACIT assessments through any and all electronic modalities including phone, web and handheld devices. [more]
HERCULES, CA – December 7, 2009 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the availability of its first iPhone app for free download through Apple’s iTunes App Store. [more]
Mergers & Acquisitions, Partnerships, & Collaborations 2010 – Review and Outlook
This PharmaLive Special Report analyzes the healthcare industry’s M&As of 2009, providing a comprehensive listing of companies’ M&A activity and detailing the top 20 deals within each of the Pharmaceutical, Biotechnology, Specialty, and Medical Device sectors, and previews potential M&A activity within the healthcare arena for 2010.
The introductory rate of $395 expires February 17, 2010.
